Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM

This article was originally published in The Tan Sheet

Executive Summary

Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine

You may also be interested in...



HIV/AIDS Dietary Supplement Research Sponsored By NCCAM, NINR

NCCAM is looking to fund research on the properties of botanicals used by HIV/AIDS patients, including their potential antiretroviral properties as well as their ability to alleviate the side effects of HIV/AIDS drugs or to interact with such drugs

HIV/AIDS Dietary Supplement Research Sponsored By NCCAM, NINR

NCCAM is looking to fund research on the properties of botanicals used by HIV/AIDS patients, including their potential antiretroviral properties as well as their ability to alleviate the side effects of HIV/AIDS drugs or to interact with such drugs

HIV/AIDS Dietary Supplement Research Sponsored By NCCAM, NINR

NCCAM is looking to fund research on the properties of botanicals used by HIV/AIDS patients, including their potential antiretroviral properties as well as their ability to alleviate the side effects of HIV/AIDS drugs or to interact with such drugs

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093562

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel